Journal Mobile Options
Table of Contents
Vol. 113, No. 2, 2005
Issue release date: March 2005
Add to my selection Citation Download
Acta Haematol 2005;113:150–151
(DOI:10.1159/000083455)
Brief Communication

Idiopathic Systemic Capillary Leak Syndrome Misdiagnosed and Treated as Polycythemia vera

Doubek M. · Brychtova Y. · Tomiska M. · Mayer J.
Department of Internal Medicine – Hematology/Oncology, University Hospital Brno, Brno, Czech Republic Acta Haematol 2005;113:150–151 (DOI:10.1159/000083455)

Abstract

 

 goto top of outline Author Contacts

Michael Doubek, MD
Department of Internal Medicine – Hematology/Oncology
University Hospital Brno, Jihlavska 20
CZ–62500 Brno (Czech Republic)
Tel. +420 532233642, Fax +420 532233603, E-Mail mdoubek@fnbrno.cz


 goto top of outline Article Information

Received: April 14, 2004
Accepted after revision: July 6, 2004
Number of Print Pages : 2


 goto top of outline Publication Details

Acta Haematologica

Vol. 113, No. 2, Year 2005 (Cover Date: Released March 2005)

Journal Editor: I. Ben-Bassat, Tel Hashomer
ISSN: 0001–5792 (print), 1421–9662 (Online)

For additional information: http://www.karger.com/aha


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.